Stéphane Thomas

731 citations

35 papers · 547 indexed · h-index 13

Impact in

Microbiology top 5%
- Bacterial Infections and Vaccines
Epidemiology top 10%
- Hepatitis B Virus Studies
- Cervical Cancer and HPV Research
- Influenza Virus Research Studies
- Pneumonia and Respiratory Infections
- Herpesvirus Infections and Treatments
- Virology and Viral Diseases

Papers in ⓘ

Microbiology 13
- Bacterial Infections and Vaccines 13
Epidemiology 29
- Pneumonia and Respiratory Infections 10
- Hepatitis B Virus Studies 8
- Herpesvirus Infections and Treatments 7
- Influenza Virus Research Studies 5
- Virology and Viral Diseases 5

Co-authors: Anne Fiquet (12 shared papers)Martine Baudin (8 shared papers)Pierre Van Damme (3 shared papers)Timo Vesikari (7 shared papers)Alain Luxembourg (2 shared papers)Christine Sadorge (7 shared papers)Giancarlo Icardi (3 shared papers)Javier Díez‐Domingo (5 shared papers)
Journals: Vaccine (14 papers)The Pediatric Infectious Disease Journal (4 papers)Human Vaccines (3 papers)Human Vaccines & Immunotherapeutics (2 papers)BMC Infectious Diseases (2 papers)
Partner nations: France Italy United States

In The Last Decade

Stéphane Thomas

35 papers receiving 531 citations

Peers

Countries citing papers authored by Stéphane Thomas

Since Specialization

Citations

This map shows the geographic impact of Stéphane Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Thomas more than expected).

Fields of papers citing papers by Stéphane Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Thomas. The network helps show where Stéphane Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Stéphane Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphane Thomas Line = papers co-authored together Stéphane Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls The Pediatric Infectious Disease Journal ·Timo Vesikari, Nicholas Brodszki, Pierre Van Damme, Javier Díez‐Domingo, Giancarlo Icardi, Lone Kjeld Petersen, Clément Tran, Stéphane Thomas, Alain Luxembourg, Martine Baudin	2015	79
2	Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study BMC Infectious Diseases ·Pierre Van Damme, Robert Arnou, Froukje Kafeja, Anne Fiquet, Patrick O. Richard, Stéphane Thomas, Gilles Meghlaoui, Sandrine Samson, Emilio Ledesma	2010	60
3	A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men Vaccine ·Pierre Van Damme, Chris J.L.M. Meijer, Dorothee Kieninger, Anne Schuyleman, Stéphane Thomas, Alain Luxembourg, Martine Baudin	2016	57
4	A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months Vaccine ·Sven‐Arne Silfverdal, Giancarlo Icardi, Timo Vesikari, Sheryl Flores, Marco F. Pagnoni, Jin Xu, G. Frank Liu, Jon E. Stek, Florence Boisnard, Stéphane Thomas, Eddy Ziani, Andrew W. Lee	2016	32
5	Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial Vaccine ·Javier Díez‐Domingo, Thomas Weinke, Juan García de Lomas, Claudius U. Meyer, Isabelle Bertrand, Cécile Eymin, Stéphane Thomas, Christine Sadorge	2014	32
6	Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy Vaccine ·Alessandro Zanetti, Antonino Parlato, Luisa Romanò, Maria Giuseppina Desole, Giuseppe Ferrera, Filippo Giurdanella, Massimo Zuliani, Patrick O. Richard, Stéphane Thomas, Anne Fiquet	2012	28
7	Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax^®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules Human Vaccines & Immunotherapeutics ·Timo Vesikari, Roland Hardt, H. C. Rümke, Giancarlo Icardi, Jordi Montero, Stéphane Thomas, Christine Sadorge, Anne Fiquet	2013	28
8	Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial BMC Medicine ·Yves Gillet, Pirmin Habermehl, Stéphane Thomas, Cécile Eymin, Anne Fiquet	2009	26
9	A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months The Pediatric Infectious Disease Journal ·Timo Vesikari, Thomas Becker, André Vertruyen, Katleen Poschet, Sheryl Flores, Marco F. Pagnoni, Jin Xu, G. Frank Liu, Jon E. Stek, Florence Boisnard, Stéphane Thomas, Eddy Ziani, Andrew W. Lee	2016	22
10	Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age Vaccine ·Timo Vesikari, Thomas Becker, Vincent Gajdos, Anne Fiquet, Stéphane Thomas, Patrick O. Richard, Martine Baudin	2012	20
11	Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine Vaccine ·Nicholas Kitchin, Jo Southern, Rhonwen Morris, Ray Borrow, Anne Fiquet, Florence Boisnard, Stéphane Thomas, Elizabeth Miller	2009	14
12	Immunogenicity and safety of ZOSTAVAX® approaching expiry potency in individuals aged ≥50 years Human Vaccines ·Robert Arnou, Anne Fiquet, Stéphane Thomas, Christine Sadorge	2011	12
13	Results from a Randomized Clinical Trial of Coadministration of RotaTeq, a Pentavalent Rotavirus Vaccine, and NeisVac-C, a Meningococcal Serogroup C Conjugate Vaccine Clinical and Vaccine Immunology ·Timo Vesikari, Aino Karvonen, Ray Borrow, Nick Kitchin, Martine Baudin, Stéphane Thomas, Anne Fiquet	2011	12
14	Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) administered concomitantly with a booster dose of a hexavalent vaccine in 12–23-month-old infants Vaccine ·Klaus A. Deichmann, Giuseppe Ferrera, Clément Tran, Stéphane Thomas, Cécile Eymin, Martine Baudin	2015	11
15	Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy BMC Infectious Diseases ·Carlo Giaquinto, Giovanni Gabutti, Vincenzo Baldo, Marco Villa, Lara Tramontan, Nadia Raccanello, Francesco Paolo Russo, Chiara Poma, Antonio Scamarcia, Luigi Cantarutti, Rebecca Lundin, Emilia Perinetti, Xavier Cornen, Stéphane Thomas, Céline Ballandras, Audrey Souverain, Susanne Hartwig	2018	11
16	Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib) Vaccine ·Federico Martinón‐Torres, Florence Boisnard, Stéphane Thomas, Christine Sadorge, Ray Borrow	2017	10
17	Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers Vaccine ·Timo Vesikari, Ray Borrow, Xavier Da Costa, Stéphane Thomas, Cécile Eymin, Florence Boisnard, Stephen Lockhart	2018	10
18	Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy Vaccine ·Alessandro Zanetti, Maria Giuseppina Desole, Luisa Romanò, Antonio D’Alessandro, Michele Conversano, Giuseppe Ferrera, Maria Grazia Panico, Alberto Tomasi, G Zoppi, Massimo Zuliani, Stéphane Thomas, B. Soubeyrand, Cécile Eymin, Stephen Lockhart	2017	9
19	Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular Pertussis (DTaP₅), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP₃-IPV/Hib Vaccine Administered at 3, 5, and 12 Months of Age Clinical and Vaccine Immunology ·Timo Vesikari, Sven‐Arne Silfverdal, Florence Boisnard, Stéphane Thomas, Grace Mwawasi, Donna L. Reynolds	2013	8
20	The predicted persistence and kinetics of antibody decline 9 years after pre-school booster vaccination in UK children Vaccine ·Merryn Voysey, Rama Kandasamy, Ly‐Mee Yu, Martine Baudin, Christine Sadorge, Stéphane Thomas, Tessa M. John, Andrew J. Pollard	2016	8

About Stéphane Thomas

Stéphane Thomas is a scholar working on Microbiology, Epidemiology, Health, Hepatology and Virology, having authored 35 papers that have together received 547 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (13 papers), Pneumonia and Respiratory Infections (10 papers), Hepatitis B Virus Studies (8 papers), Vaccine Coverage and Hesitancy (7 papers), Herpesvirus Infections and Treatments (7 papers), Hepatitis Viruses Studies and Epidemiology (6 papers), Influenza Virus Research Studies (5 papers) and Virology and Viral Diseases (5 papers). The work is most often cited by research in Microbiology (128 citations), Epidemiology (442 citations), Health (98 citations), Virology (34 citations) and Hepatology (53 citations). Stéphane Thomas has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Anne Fiquet, Martine Baudin, Pierre Van Damme, Timo Vesikari, Alain Luxembourg, Christine Sadorge, Giancarlo Icardi, Javier Díez‐Domingo, Patrick O. Richard and Nicholas Brodszki. Their work appears in journals such as Vaccine, The Pediatric Infectious Disease Journal, Human Vaccines, Human Vaccines & Immunotherapeutics and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact